Jones Financial Companies’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.08K Hold
376
﹤0.01% 3830
2025
Q4
$4.22K Sell
376
-31
-8% -$355 ﹤0.01% 3563
2025
Q3
$4.79K Buy
407
+9
+2% +$105 ﹤0.01% 3371
2025
Q2
$4.86K Buy
398
+270
+211% +$3.4K ﹤0.01% 3139
2025
Q1
$1.79K Sell
128
-5
-4% -$78 ﹤0.01% 3268
2024
Q4
$2.12K Buy
133
+13
+11% +$257 ﹤0.01% 2986
2024
Q3
$2.85K Buy
120
+110
+1,100% +$2.51K ﹤0.01% 2583
2024
Q2
$199 Buy
+10
New +$195 ﹤0.01% 2382
2023
Q1
Sell
-2
Closed 584
2022
Q4
$0 Buy
+2
New +$49 ﹤0.01% 731
2021
Q4
Sell
-19
Closed -$1K 748
2021
Q3
$1K Buy
19
+12
+171% +$407 ﹤0.01% 631
2021
Q2
$0 Sell
7
-69
-91% -$2.85K ﹤0.01% 636
2021
Q1
$3K Hold
76
﹤0.01% 694
2020
Q4
$3K Buy
+76
New +$3.16K ﹤0.01% 545

Other funds holding AVNS

Jones Financial Companies's AVNS Position: Q1 2026 in Review

Jones Financial Companies held its Avanos Medical (AVNS) position steady in Q1 2026 at 376 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

Jones Financial Companies first reported a position in AVNS in Q4 2020 and has held it in 13 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Jones Financial Companies held 376 shares of Avanos Medical worth $5.08K as of Q1 2026.
  • Jones Financial Companies left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3830 holding.
  • Jones Financial Companies first reported a position in Avanos Medical in Q4 2020 and has held it in 13 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.